A Preliminary Report Regarding the Morphological Changes of Nano-Enabled Pharmaceutical Formulation on Human Lung Carcinoma Monolayer and 3D Bronchial Microtissue

• Published in: Medicina (Kaunas, Lithuania) Vol. 60; no. 2; p. 208
• Main Authors: Prodan-Bărbulescu, Cătălin, Watz, Claudia-Geanina, Moacă, Elena-Alina, Faur, Alexandra-Corina, Dehelean, Cristina-Adriana, Faur, Flaviu Ionut, Grigoriţă, Laura Octavia, Maghiari, Anca Laura, Tuţac, Paul, Duţă, Ciprian, Bolintineanu, Sorin, Ghenciu, Laura Andreea
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01.01.2024
• Subjects: A549; Antineoplastic Agents - therapeutic use; Biocompatibility; Camellia sinensis; Cancer; Cancer therapies; Carcinoma; Cell death; Chemotherapy; Cytotoxicity; Drug Carriers - therapeutic use; Drug Compounding - methods; Drug delivery systems; Drug therapy; Drugs; EpiAirwayTM; Humans; Lipids; Lung - pathology; Lung cancer; Lung Neoplasms - pathology; maghemite; magnetite; Medical research; Nanoparticles; Nanotechnology; Ocimum basilicum; Particle Size; Pharmaceuticals; Toxicity; Massachusetts; Germany; Romania; magnetite; EpiAirwayTM; Camellia sinensis; maghemite; A549; Ocimum basilicum

: Nowadays, the development of enabled pharmaceutical nanoparticles of solid lipid type is continuously growing, because they have the potential to be used for targeted drug release leading to an increased effect of chemotherapy, being used in lung cancer nano-diagnosis and nano-therapy. The current...